We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,149 hedge funds and large institutions have $289B invested in Johnson & Johnson in 2025 Q1 according to their latest regulatory filings, with 253 funds opening new positions, 1,703 increasing their positions, 1,841 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more call options, than puts

Call options by funds: $4.67B | Put options by funds: $2.57B

71% more first-time investments, than exits

New positions opened: 253 | Existing positions closed: 148

55% more funds holding in top 10

Funds holding in top 10: 146226 (+80)

12% more capital invested

Capital invested by funds: $257B → $289B (+$31.9B)

1% more funds holding

Funds holding: 4,1064,149 (+43)

0.4% more ownership

Funds ownership: 72.03%72.43% (+0.4%)

7% less repeat investments, than reductions

Existing positions increased: 1,703 | Existing positions reduced: 1,841

Holders
4,149
Holders Change
+43
Holders Change %
+1.05%
% of All Funds
55.6%
Holding in Top 10
226
Holding in Top 10 Change
+80
Holding in Top 10 Change %
+54.79%
% of All Funds
3.03%
New
253
Increased
1,703
Reduced
1,841
Closed
148
Calls
$4.67B
Puts
$2.57B
Net Calls
+$2.09B
Net Calls Change
+$1.56B
Name Holding Trade Value Shares
Change
Change in
Stake
Voloridge Investment Management
4151
Voloridge Investment Management
Florida
-$140M -969,956 Closed
TAM
4152
Talaria Asset Management
Australia
-$81M -559,800 Closed
WAM
4153
Weiss Asset Management
Massachusetts
-$45.7M -316,296 Closed
Point72 Asset Management
4154
Point72 Asset Management
Connecticut
-$47.8M -305,726 Closed
PAMP
4155
Polar Asset Management Partners
Ontario, Canada
-$39M -270,000 Closed
WRBC
4156
W.R. Berkley Corp
Connecticut
-$38.9M -268,700 Closed
CM
4157
Crestline Management
Texas
-$34.5M -238,615 Closed
Capstone Investment Advisors
4158
Capstone Investment Advisors
New York
-$24.3M -155,000 Closed
TAM
4159
Troy Asset Management
United Kingdom
-$20.5M -141,813 Closed
CCM
4160
Cutter Capital Management
New York
-$20.5M -141,572 Closed
CPCPP
4161
Canada Post Corporation Pension Plan
Canada
-$19.9M -137,449 Closed
Simplex Trading
4162
Simplex Trading
Illinois
-$18.5M -118,269 Closed
TC
4163
TwinBeech Capital
New York
-$15.7M -108,857 Closed
TAF
4164
Tredje AP-fonden
Sweden
-$15.6M -107,708 Closed
Walleye Trading
4165
Walleye Trading
New York
-$16.4M -104,536 Closed
AF
4166
Ally Financial
Michigan
-$15M -104,000 Closed
CGPCS
4167
Capital Group Private Client Services
California
-$13.5M -93,302 Closed
CSS
4168
Cubist Systematic Strategies
Connecticut
-$11.5M -73,197 Closed
Wolverine Trading
4169
Wolverine Trading
Illinois
-$11.4M -72,736 Closed
ATI
4170
Act Two Investors
California
-$10.5M -72,656 Closed
SW
4171
SVB Wealth
Massachusetts
-$10.4M -71,949 Closed
MSE
4172
MUFG Securities EMEA
United Kingdom
-$9.69M -67,000 Closed
Group One Trading
4173
Group One Trading
Illinois
-$10.3M -66,036 Closed
ACM
4174
Aquatic Capital Management
Illinois
-$9.39M -64,938 Closed
VF
4175
Virtu Financial
New York
-$8.69M -60,104 Closed

JNJ Hedge Fund Activity: Q1 2025 in Review

4,149 of the 7,462 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2025, worth a combined $289B — up 12% from $257B a quarter earlier.

Buyers outnumbered sellers: 253 funds opened new JNJ positions and 148 closed out — a net gain of 105 holders — while 1,703 added to existing stakes and 1,841 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $2.39B. The largest seller was T. Rowe Price Associates, cutting an estimated $967M.

  • 4,149 institutional investors held Johnson & Johnson (JNJ) as of Q1 2025, up from 4,106 in Q4 2024.
  • Funds reported $289B of Johnson & Johnson stock for Q1 2025, up 12% quarter-over-quarter.
  • 253 funds opened new Johnson & Johnson positions in Q1 2025 and 148 closed out, a net change of +105 holders.
  • The largest Johnson & Johnson buyer in Q1 2025 was JP Morgan Chase, an estimated $2.39B added.
  • The largest Johnson & Johnson seller in Q1 2025 was T. Rowe Price Associates, an estimated $967M sold.

Based on aggregated 13F filings for Q1 2025.